Scholars Central

Conference abstractPublished 7 Mar 2019

Recombinant L-asparaginase induction process for pharmaceutical application

Authors: Larissa Pereira Brumano, Flaviana da Silva Chaves, Adalberto Pessoa Junior

University of Sao Paulo, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

L-asparaginase (ASNase) is an important biopharmaceutical used in the treatment of lymphatic system oncological diseases, mainly acute lymphoblastic leukemia (LLA). LLA is the most common type of cancer in childhood, but it can also occur in adults, and expected to afflict over 53,000 people worldwide by 2020. The treatment with ASNase presents several side effects, mainly allergic reactions and inactivation. Aiming to overcome these problems, a recombinant E. coli BL21(DE3) able to overexpress protease resistant ASNase was constructed. ASNase protease resistance is promising since higher immune response occurs when the enzyme is hydrolyzed and protease activity leads to its inactivation and the half-life decrease. To improve this ASNase production, induction conditions studies were performed. E. coli was cultivated in defined medium with 5g/L of glucose and the induction was carried using IPTG in different stages of exponential growth phase (0.2, 0.5 and 0.8 gcell/L). Also, IPTG concentration per cell mass was evaluated (1.3, and 3.0 mMol/gcell). Enzyme activity (U/mL and U/ gcell) was used as response. Results showed that the inducion in advanced stage of exponential phase (0.8 gcell/L) was more advantageous, resulting in a maximum of 1.04 U/mL (527 U/gcell) and a higher cell concentration (1.97 gcell/L) in the end of the cultivation (18 h). When the induction was performed with 0.2 gcell/L (beginning of exponential phase) the glucose was not totally consumed. No statistic difference was observed among the IPTG concentrations, indicating that lower IPTG concentration could be used. The study of the induction process is necessary not only to obtain a high protein expression, but also to try to reduce production costs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Larissa Pereira Brumano”
  • BylineArticles whose byline prints “Flaviana da Silva Chaves”
  • BylineArticles whose byline prints “Adalberto Pessoa Junior”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels